Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19 is a research paper published in Journal of Virology (2024). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01 AI169022, 75N93021C00016
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: HHSN272201700036I/75N93020F00001
Alvin J. Siteman Cancer Center
Grant: SCC P30CA091842
Foundation for Barnes-Jewish Hospital
Grant: BJHF 4984
NCI NIH HHS
Grant: P30 CA091842
NIAID NIH HHS
Grant: 75N93021C00016
NIAID NIH HHS
Grant: R01 AI169022
FWCI
4.34
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals